Search

everythinglearnresearchcommunity

for

Search:↓

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

High levels of prolactin in the blood can be linked to widespread hair loss.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Aromatase gene variation may increase female hair loss risk.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Skin produces different hormones depending on body part and sex, and a new method can measure them.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Gut microbes significantly affect brain steroid levels.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Combining minoxidil and spironolactone is more effective for female hair loss, but minoxidil alone is sufficient after 6 months.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

Hypothyroidism may cause certain types of hair loss.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Women with PCOS may be more likely to have gum disease than healthy women.